![]() |
Link a Tocris |
![]() |
Información esencial Tocris |
![]() |
Posters y Guias Tocris |
![]() |
Infromación Gnral Reactivos |
Empresa de biotecnología con sede en Houston, cerca del Centro Médico de Texas, centrada en I+D, fabricación y comercialización de Proteínas, Anticuerpos y Kits de Inmunoensayo de altísima calidad.
CD27; S152; T14; Tp55; CD27L receptor;
CD30; KI-1; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30
CD30; KI-1; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30
CD30; KI-1; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30
CD30; KI-1; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30
CD137; CDw137; 4-1BB; ILA; Induced By Lymphocyte Activation; T-cell antigen 4-1BB homolog
CD137; CDw137; 4-1BB; ILA; Induced By Lymphocyte Activation; T-cell antigen 4-1BB homolog
CD137; CDw137; 4-1BB; ILA; Induced By Lymphocyte Activation; T-cell antigen 4-1BB homolog
CD137; CDw137; 4-1BB; ILA; Induced By Lymphocyte Activation; T-cell antigen 4-1BB homolog
CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand
CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand
CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand